Skip to content

EV / sales at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
6.5×+1.8×
Stryker logo
StrykerSYK
5.4×-1.3×
Boston Scientific logo
Boston ScientificBSX
-1.5×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
2.9×-0.7×
Medtronic logo
MedtronicMDT
3.6×-0.4×
Intuitive Surgical logo
Intuitive SurgicalISRG
19.6×-2.4×

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0.0×
Current ratio4.6×+0.1×

Where this comes from

Calculated from Globus Medical’s reported figures.

Based on the most recent quarter.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's EV / sales?
Globus Medical (GMED) reported EV / sales of 3.6× in Q1 2026.
How has Globus Medical's EV / sales changed year-over-year?
Globus Medical's EV / sales decreased by 6.4% year-over-year, from 3.9× to 3.6×.
What is the long-term trend for Globus Medical's EV / sales?
Over 5 years (2020 to 2025), Globus Medical's EV / sales has grown at a -13.9% compound annual growth rate (CAGR), from 8.1× to 3.8×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.